Neurosurgical management of low- and intermediate-grade gliomas

Seminars in Radiation Oncology

Volumn 11, Issue 2, 2001, Pages 113-123

  Tatter, Stephen B ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; MANNITOL;

BRACHYTHERAPY; CANCER GRADING; COMPUTER ASSISTED TOMOGRAPHY; CRANIOTOMY; ENDOSCOPIC SURGERY; GENE THERAPY; GLIOMA; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STEREOTAXIC SURGERY; SURGICAL TECHNIQUE;

EID: 0035074247     PISSN: 10534296     EISSN: None     Source Type: Journal    
DOI: 10.1053/srao.2001.21430     Document Type: Article

References (67)

1. 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma
2. Prognostic value positron emission tomography with [18F]flouro-deoxy glucose in the low grade glioma
3. Accurate, noninvasive diagnosis of human brain tumors by using proton
4. Age and the risk of anaplasia in magnetic resonance-nonenhancing supratentorial cerebral tumors
5. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma
6. Effect of the extent of surgical resection on survival and quality of life in patients with supratentorial glioblastomas and anaplastic astrocytomas
7. Supratentorial gliomas. Surgical considerations and immediate postoperative results. Gross total resection versus partial resection
8. Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome
9. The role of surgery in the management of supratentorial intermediate and high-grade astrocytomas in adults
10. Supratentorial low-grade astrocytomas in adults
11. The case for resective surgery
12. The relationship between survival and the extent of resection in patients with supratentorial malignant gliomas
13. Suspected low-grade glioma: Is deferring treatment safe?
14. Surgery for adult low-grade primary brain tumors
15. The low-grade glioma debate: Evidence defending the position of early radiation therapy
16. Oligodendrogliomas. The Mayo Clinic experience
17. The influence of extent of surgery on the neurological function and survival in maligant glioma. A retrospective analysis in 243 patients
18. Low grade glioma of the cerebral hemispheres in adults: A retrospective analysis of 88 cases
19. Biopsy of low-grade astrocytomas
20. Brain astrocytomas: Biopsy, then irradiation
21. Survival after stereotactic biopsy and irradiation of cerebral non-anaplastic, nonpilocytic astrocytoma
22. Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres
23. Low-grade astrocytomas: Treatment results and prognostic variables
24. Low-grade cerebral astrocytomas. Survival and quality of life after radiation therapy
25. Postoperative radiotherapy of supratentorial low-grade gliomas
26. Prognostic factors in well-differentiated cerebral astrocytomas in the adult
27. Surgery for low-grade glioma: Rationale for early intervention
28. Low-grade glioma: The case for delayed surgery
29. Treatment and survival of low-grade astrocytoma in adults - 1977-1988
30. Survival of patients with well-differentiated astrocytomas diagnosed in the era of computed tomography
31. Effect of large doses of methylprednisolone on supratentorial intracranial tumors. A clinical and CAT scan evaluation
32. Role of radiation therapy in the management of low-grade glioma in adults
33. Supratentorial gliomas: A comparative study by grade and histologic type
34. Variations in the natural history and survival of patients with supratentorial low-grade astrocytomas
35. Reoperation for recurrent glioblastoma and anaplastic astrocytoma
36. Neuroendoscopic approach to intraventricular lesions
37. Neuroendoscopic approach to tectal tumors: A consecutive series
38. A technique for interactive image-guided neurosurgical intervention in primary brain tumors
39. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases. Final report of RTOG protocol 90-05
40. Efficacy and feasibility of stereotactic radiosurgery in the primary management of unfavorable pediatric ependymoma
41. The role of radiosurgery for glial neoplasms
42. The role of radiosurgery in the treatment of malignant brain tumors
43. Radiosurgery for brain tumours: Is there a proven benefit?
44. Stereotactic radiosurgery for glial neoplasms of childhood
45. Survival benefit of stereotactic radiosurgery for patients with malignant glial neoplasms
46. Stereotactic radiosurgery for glial neoplasms
47. Gamma knife for glioma: Selection factors and survival
48. Early outcomes after stereotactic radiosurgery for growing pilocytic astrocytomas in children
49. Brachytherapy of recurrent malignant brain tumors with removable high-activity iodine-125 sources
50. Results of stereotactic brachytherapy used in the initial management of patients with glioblastoma
51. Interstitial brachytherapy for newly diagnosed patients with malignant glioma. The UCSF experience
52. Brachytherapy of brain tumors
53. Use of the RTOG recursive partitioning analysis to validate the benefit of iodine-125 implants in the primary treatment of malignant gliomas
54. Phosphorus-32 intracavitary irradiatin of cysytic craniopharyngiomas. Current technique and long term results
55. Integrative treatment of gliomas
56. Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults
57. Aggressive oligodendroglioma. A chemosensitive tumor
58. The treatment of oligodendrogliomas and mixed oligodendroglioma-astrocytomas with PCV chemotherapy
59. Procarbazine, lomustine, and vincristine (PCV) chemotherapy for grade III and grade IV oligoastrocytomas
60. Neoadjuvant procarbazine, CCNU, and vincristine for anaplastic and aggressive oligodendroglioma
61. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas
62. Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells
63. Intraventricular immunotoxin therapy for leptomeningeal neoplasia
64. Immunotoxins for brain tumor therapy
65. Astrocytomas of the cerebellum. A comparative clinicopathologic study of pilocytic and diffuse astrocytomas